phenazopyridine has been researched along with nitrofurantoin in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (41.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Bender, A; Czobor, P; Jelinek, B; Málnási-Csizmadia, A; Peragovics, Á; Simon, Z; Tombor, L; Végner, L | 1 |
Aswakun, P; Surmann, P | 1 |
Eggers, B; Strothmann, G | 1 |
Charles, JC; Jones, GW | 1 |
Ebbinghaus, KD | 1 |
Winter, CC | 1 |
Amábile-Cuevas, CF; Arredondo-García, JL | 1 |
Ghimire, KB; Nepal, B | 1 |
12 other study(ies) available for phenazopyridine and nitrofurantoin
Article | Year |
---|---|
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity | 2013 |
[Simultaneous polarographic determination of nitrofurantoin and phenazopyridine in tablets].
Topics: Aminopyridines; Nitrofurantoin; Phenazopyridine; Polarography; Tablets | 1985 |
[Febrile exanthema after nitrofurantoin administration].
Topics: Aged; Drug Combinations; Drug Hypersensitivity; Exanthema; Female; Fever; Humans; Nitrofurantoin; Phenazopyridine; Prednisolone; Pyelonephritis; Sulfadiazine; Urinary Tract Infections | 1974 |
Comparative study of macrodantin and pyridium in controlling morbidity following surgery of the lower urinary tract.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Azo Compounds; Bacterial Infections; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Nitrofurantoin; Phenazopyridine; Postoperative Complications; Pyridines; Urinary Catheterization; Urinary Tract; Urinary Tract Infections | 1972 |
[Ambulatory treatment of urinary tract infections].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Anti-Infective Agents, Urinary; Child; Female; Humans; Male; Middle Aged; Nitrofurantoin; Phenazopyridine; Sulfadiazine; Urinary Tract Infections | 1970 |
Long-term drug therapy for urinary tract infections.
Topics: Adult; Anesthetics, Local; Child; Humans; Mandelic Acids; Nitrofurantoin; Phenazopyridine; Sulfamethizole; Sulfathiazoles; Tetrazolium Salts; Urinary Tract Infections | 1967 |
Nitrofurantoin, phenazopyridine, and the superoxide-response regulon soxRS of Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Genotype; Microbial Sensitivity Tests; Nitrofurantoin; Phenazopyridine; Regulon; Trans-Activators; Transcription Factors | 2013 |
Dyspnea after treatment of recurrent urinary tract infection.
Topics: Aged; Anti-Infective Agents, Urinary; Drug Therapy, Combination; Dyspnea; Female; Follow-Up Studies; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Humans; Nitrofurantoin; Phenazopyridine; Recurrence; Urinary Tract Infections | 2013 |